i take diltiazem for my a fib. i am allegic to warfarin. i have found nattokinase (cardiokinase) from www.purepresciptions.com to really work fantastic for me- no danger of clots. my doctor and i am at an impasse because he wants me to…

Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.: i take diltiazem for my a fib. i am allegic to warfarin. i have found nattokinase (cardiokinase) from www.purepresciptions.com to really work fantastic for me- no danger of clots. my doctor and i am at an impasse because he wants me to take the new coumadin so he can do the shock to the heart. i am living fine with the two supplements. agree or disagree?
Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.): no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:
What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.)
Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.)
Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
Describe any health-related risks, side effects, or harms that you are concerned about.

Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?

yes

Which priority area(s) and population(s) does this topic apply to? (check all that apply)

Describe why this topic is important.: how do you handle afib without coumandin.
What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.): because nobody knows the answer
Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.): yes
If yes, please explain:: see above

How will an answer to your research question be used or help inform decisions for you or your group?: natto instead of rat poison
Describe the timeframe in which an answer to your question is needed.
Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.

Other Information About You: (optional)

Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate): natto instead of rat poison

Are you making a suggestion as an individual or on behalf of an organization?: Individual

Please tell us how you heard about the Effective Health Care Program: your website

Effective Health Care Program